Literature DB >> 11724309

Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.

K Inoue1, Y Kawahito, Y Tsubouchi, R Yamada, M Kohno, Y Hosokawa, D Katoh, D Bishop-Bailey, T Hla, H Sano.   

Abstract

The peroxisome proliferator-activated receptor (PPAR)-gamma is a member of the steroid nuclear receptors. Recent studies have demonstrated that PPAR-gamma is expressed in several cancer cells. We examined the PPAR-gamma expression in both normal lung and major types of human lung cancer. The expression of PPAR-gamma mRNA was detected in 2 out of 3 normal lung tissues and its protein was detected in 3 out of 5 normal lung tissues. In contrast, a small cell carcinoma cell line and all other types of lung cancer tissues expressed PPAR-gamma mRNA and its protein. Immunoreactive PPAR-gamma is strongly expressed in cancer cells and moderately in mononuclear cells, endothelial cells and fibroblasts of lung cancer tissues. Our results suggest that PPAR-gamma may play an important role in the pathogenesis and/or progression of lung cancer, and may be a novel therapeutical target for therapy of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724309

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

1.  Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.

Authors:  Costantinos Giaginis; Ekaterini Politi; Paraskevi Alexandrou; John Sfiniadakis; Gregory Kouraklis; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

Review 2.  Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.

Authors:  Jihan Youssef; Mostafa Badr
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.

Authors:  S Giannini; M Serio; A Galli
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 4.  Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.

Authors:  Ajaya Kumar Reka; Moloy T Goswami; Rashmi Krishnapuram; Theodore J Standiford; Venkateshwar G Keshamouni
Journal:  Lung Cancer       Date:  2011-02-26       Impact factor: 5.705

5.  The use of Cox-2 and PPARγ signaling in anti-cancer therapies.

Authors:  Lucia Knopfová; Jan Smarda
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

6.  Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.

Authors:  Lijuan Zhan; Hao Zhang; Qiang Zhang; Courtney G Woods; Yanyan Chen; Peng Xue; Jian Dong; Erik J Tokar; Yuanyuan Xu; Yongyong Hou; Jingqi Fu; Kathy Yarborough; Aiping Wang; Weidong Qu; Michael P Waalkes; Melvin E Andersen; Jingbo Pi
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

7.  PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.

Authors:  Dipak Panigrahy; Samuel Singer; Lucy Q Shen; Catherine E Butterfield; Deborah A Freedman; Emy J Chen; Marsha A Moses; Susan Kilroy; Stefan Duensing; Christopher Fletcher; Jonathan A Fletcher; Lynn Hlatky; Philip Hahnfeldt; Judah Folkman; Arja Kaipainen
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.

Authors:  Min Zhang; Ping Zou; Ming Bai; Yang Jin; Xiaonan Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

9.  Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.

Authors:  M Hetzel; D Walcher; M Grüb; H Bach; V Hombach; N Marx
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

10.  PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.

Authors:  Linda L Eastham; Caroline N Mills; Richard M Niles
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.